Post by UCL Translational Research Office (TRO)

UCL ranks second in the UK for research power and hosts over 1,800 biomedical research groups — a distinction that’s no coincidence, but the result of key strengths that set us apart. Last week, Jane K. (Director) and Pamela Tranter (Head of the Translational Research Group) attended the Joint BRC and UK Clinical Research Facility (UKCRF) Network Conference in Birmingham. They led an interactive workshop with around 30 research colleagues from across the UK’s biomedical research ecosystem, sharing UCL’s experience and best practice in driving translational success. Some of UCL's translational success factors at a glance: ✅ Extensive biomedical infrastructure We partner with nine hospitals and three Biomedical Research Centres (BRCs), with joint academic-clinical appointments that accelerate translation. ✅ Comprehensive translational support The UCL Translational Research Office supports a wide range of therapeutic areas, helping secure funding and build partnerships that deliver clinical and commercial impact. ✅ A leading product pipeline We provide proof-of-concept funding for early to mid-stage research, de-risking projects and maximising their potential. ✅ A diverse translational culture and talent pipeline Through the UCL Therapeutic Innovation Networks, we support early career researchers with training, knowledge exchange and exposure — nurturing the next generation of translational leaders.   We’d love to hear your best practice too. And if you’re a UCL researcher, get in touch to explore how we can support your healthcare innovation journey. Contact us: bit.ly/3GcxCWz NIHR University College London Hospitals Biomedical Research Centre NIHR (National Institute for Health and Care Research)   #CRFBRC25 #TranslationalResearch #HealthcareInnovation